Background: Reactive thrombocytosis (RT) in pediatric patients is common, but usually without symptoms. The incidence of RT is different depending on age. Mostly, we reason that RT is a phenomenon, nevertheless the diagnostic value of RT is little known. Therefore, the aim of this study was to determine the association of RT and clinical or laboratory characteristics in pediatric diseases. Methods: We retrospectively analyzed the medical records of pediatric patients hospitalized at Wan Fang hospital from January 2002 to July 2009. Thrombocytosis was defined as a platelet count more than 500 Â 10 9 /L. There were 822 patients enrolled to this study. The clinical parameters, including age, gender, disease type, and hospitalization days, were investigated. The association between RT and clinical manifestations and the relationship of leukocytes, hemoglobin, C-reactive protein, and platelet counts were analyzed. Results: The overall incidence of RT in hospitalized pediatric patients was 6.3%. Infants had a significantly higher incidence (11.3%, p < 0.001). Mild RT was found in most patients (83.6%). Infections (75.4%) were the most common cause, followed by perinatal diseases (11.1%). The relationship of RT and age revealed a positive correlation (p Z 0.045, r Z 0.70 after adjustment). The degree of RT was an independent factor for hospitalization days (p < 0.001, r Z 0.126 after adjustment). There was a positive correlation between white blood (J.-L. Wang).
Introduction
Thrombocytosis is often defined as platelet count more than 500 Â 10 9 /L. 1 Secondary or reactive thrombocytosis (RT), in contrast to primary thrombocytosis, is common, often seen in pediatric hospitalized patients. The estimated incidence of RT among hospitalized children is 6e15%, and it varies with age, with the highest rate in infants, then becoming more infrequent in older children. 2 This may be because of high thrombopoietin levels in the neonatal period, which fall gradually with age. 3 The most common causes of RT are infections, chronic inflammation, anemia, tissue damage, prematurity, and neoplasia. 1, 4 In general, childhood RT is a benign condition and antithrombotic prophylaxis treatment is not necessary. 5 The relationship between RT and pediatric diseases, however, is seldom reported. In children, RT might be related to the severity of lower respiratory tract infections, 6 whereas another study suggests that RT has no relationship to the degree of inflammation with community-acquired pneumonia. 7 Therefore, the role of RT still needs to be determined in pediatric diseases.
To understand the clinical relevance of RT in pediatric diseases, we retrospectively reviewed the medical records of children with RT in a single institute during an 8-year period. The aim of our present study was to analyze the relationship between RT and specific clinical or laboratory parameters, further elucidating the diagnostic value of RT in pediatric diseases.
Materials and Methods

Patient inclusion and methods
We reviewed the medical records of patients between birth and 18 years old admitted to Wan Fang Hospital from January 2002 to July 2009. The laboratory data of complete blood count and C-reactive protein (CRP) was obtained in all patients. White blood cell (WBC) count, hemoglobin (Hb), and platelets were determined using ethylenediaminetetraacetic acid-anticoagulated whole blood on an automatic cell counter (Beckman Coulter LH750; Fullerton, CA, USA) and measurement of CRP was performed by an immunoturbidimetric method (Beckman LXi725, Krefeld, Germany). The criteria for inclusion of RT were patients with platelet count more than 500 Â 10 9 /L, recovering to the normal range after admission. We excluded patients with primary thrombocytosis. RT patients were divided into four groups, Grade I (mild, 500 Â 10 9 /L < platelets 700 Â 10 9 /L), Grade II (moderate, 700 Â 10 9 /L < platelets 900 Â 10 9 /L), Grade III (severe, 900 Â 10 9 /L < platelets 1000 Â 10 9 /L), and Grade IV (extreme, platelets > 1000 Â 10 9 /L). 1 The association between clinical parameters, including age, gender, disease type, hospitalization days, and the degree of RT was analyzed and the relationship of WBC count, Hb, and CRP levels at peak platelet count and RTwas investigated. The study was approved by the institutional review board of Taipei Medical University.
Statistical analysis
We used SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, USA) for statistical analysis. Analysis of variance and Chi-square tests were used to analyze the association between age, gender, disease type, hospitalization days, and the degree of RT. Linear regression analyses were used to investigate the relationship of platelet count and age as well as hospitalization days, and further, we evaluated the correlation between platelet count and laboratory parameters. The correlation coefficient (r) was used to assess the intervariable reliability. A p value less than 0.05 was regarded as statistically significant.
Results
During the period, there were 14,050 pediatric hospitalized patients excluding healthy newborns, and 887 patients were found to have RT on admission or during hospitalization. Only the highest platelet count was used for analysis when a patient had more than two hospitalizations. As a result, only 822 patients were included in this study. The Figure 1 The incidence of childhood reactive thrombocytosis stratified by age (Chi-square test, p < 0.001). overall incidence of RT among hospitalized pediatric patients in this study was 6.3%. We investigated the incidence according to different age and found that RT was more significantly likely seen in patients younger than 1 year (11.3%, p < 0.001, Figure 1 ); the incidence decreased with age. In particular, infants younger than 3 months old accounted for 34.9% of all RT patients.
In RT patients, there was a male preponderance, with a ratio of 1.36:1, and the mean age was 20.1 AE 32.45 months old. The percentages of Grade I, II, III, and IV RT were 83.6%, 12.9%, 1.9%, and 1.6%, respectively. The age in extreme RT was significantly older (p Z 0.005; Grade I vs.
Grade IV, p Z 0.013 post hoc, Tables 1 and 2) . Such tendency was also found after linear regression analyses (p Z 0.045, r Z 0.70 after adjustment, Table 3 ). Importantly, we found that the degree of RT was significantly associated with hospitalization days (p Z 0.001; Grade I vs. Grade II, p Z 0.001 post hoc, Tables 1 and 2) and not related to gender or disease type. After multivariate regression analyses, the platelet count still had a significantly positive correlation to hospitalization days (p < 0.001, r Z 0.126 after adjustment, Table 3 ).
With regard to the etiologies of RT, we divided the disease types into six groups. We found that the most common cause was infections (75.4%), followed by perinatal diseases (11.1%). Table 4 shows the distribution of etiologies. No thrombotic or hemorrhagic complications were seen in any patients, even in extreme RT.
We further evaluated the relationship between platelet count and WBC count, Hb, and CRP levels. The degree of RT was positively correlated with the elevation of WBC counts (p Z 0.002, r Z 0.017). In contrast, the degree of RT was inversely correlated with Hb level (p < 0.001, r Z À0.193), but there was no correlation to CRP level (p Z 0.239, r Z 0.046), as shown in Figure 2 
Discussion
To our knowledge, few investigations on a large scale have addressed the clinical significance of RT in pediatric patients. In our retrospective study, the overall incidence of RT was 6.3%, with infants showing a significantly higher incidence (11.3%, p < 0.001), especially in patients less than 3 months old. In most cases, the platelet count was only slightly elevated (mild), found in reported studies with a similar distribution. 1, 8, 9 RT occurred in a variety of clinical conditions, and infections (75.4%) were the most common cause. However, we found that there was a significant correlation between age and the degree of RT (p Z 0.045, r Z 0.70 after adjustment), and older children being more likely to have extreme RT. Furthermore, the degree of RT was an independent factor with respect to the hospitalization days (p < 0.001, r Z 0.126 after adjustment), although patients with Grade III and IV RT did not have longer hospitalization. The small numbers of the two groups might have caused the difference. Intriguingly, we discovered that there was a significantly positive correlation to WBC count (p Z 0.002, r Z 0.107) and a significantly inverse correlation to Hb level (p < 0.001, r Z À0.193) related to the degree of RT.
The age distribution was exceptionally high in neonates, infants, and young children, 2 and similar findings were made in our study. The high platelet count is believed to have been caused by the bone marrow precursors responding to stress in young children. 3, 10 However, the relationship of the degree of RT and age is seldom reported. According to a study by Chan et al, 10 marked RT (>900 Â 10 9 /L) was commonly seen in young children (median age, 9 months). But, we discovered that the older patients had a tendency to have a higher elevation in platelet count. Different underlying diseases, which we encountered in our study, caused the degree of inflammation, and the low percentage in severe and extreme RT patients (only 3.5%) perhaps allowed the differences.
Recently, research has suggested that platelets play an active role in microbial host defenses and are an integral part of inflammation through adaptive and innate immune response, in addition to their function in hemostasis. 11e13 The elevation of platelet count could reflect the degree of inflammation, and previous studies have shown that the platelet count could be a useful clinical marker in children with severe lower respiratory tract infection. In cancer patients, however, thrombocytosis was associated with poor prognosis. 6, 14 Interleukin-6, which plays a prominent role in response to inflammation, may be a key mediator of the increased synthesis of thrombopoietin and consequent RT. 15, 16 In pediatric patients, hospitalization days might be related to the degree of inflammation, therefore, the degree of RT could be used to predict the length of hospitalization in patients with pediatric diseases.
Clinical complications do not occur in patients with RT, regardless of the degree of the platelet count elevation, unless the underlying systemic disorders predispose patients to them. 17 In contrast, bleeding and thrombotic complications are the major clinical complications in patients with primary thrombocytosis. Qualitative platelet abnormalities and endothelial dysfunction contribute to hemostatic complications. 17 Therefore, antithrombotic treatment for prophylaxis needs to be used in primary thrombocytosis and not in RT.
Regarding the mechanisms of leukocytosis and the decrease of Hb levels in childhood RT, they seem unclear. During inflammation, platelets contribute to chemotaxis interactions by stimulating adhered leukocytes, regulating chemokine synthesis, 11, 12 and increasing inflammatory cytokines, such as interleukin-6, and the granulocytecolony stimulating factor, which stimulates the production of granulocytes. 18, 19 In addition, anemia is caused by a response to inflammation because of the shortening of the lifespan of red blood cells, impaired erythropoietin production, and iron metabolism by inflammatory cytokines. 20,21 Based on the above theories, we are able to explain the phenomenon of RT accompanied by increased WBC count and decreased Hb level.
In conclusion, we have identified the incidence of childhood RT during different ages and its associations with clinical characteristics. The degree of RT was related to age and reflected the degree of inflammation as a predictor of hospitalization days in pediatric diseases. Further research considering the effects of inflammatory cytokine on platelets is needed to prove our opinion. 
